TH and nervous system disorder: The administration of THIQs to a wide range of animal models (primates and mice) was found to reduce the tyrosine hydroxylase (TH) activity, the enzyme responsible for converting tyrosine to dopamine, and dopamine levels in the brain [13], knowing that this reduction implicated in different nervous system diseases.